There’s a very nice article today on the MedPage Today web site about the medical value of “at-home genetic testing” (i.e., the sorts of tests available from companies like 23&Me and some others). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: genetic, test, utility, value | 3 Comments »
We often hear — from patients themselves and also from spouses and partners — about what they see as a failure of some physicians to address the problems that they want to discuss … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: Multidisciplinary, nurse, responsibility, team, value | 8 Comments »
There is growing recognition that the patient’s satisfaction or regret with his treatment decision is more than just a matter of whether he is happy with the oncological outcome. Satisfaction/regret is the product of many variables, including how well he understood his options, his interactions with his doctors, the side effects he suffered and when he suffered them, his expectations about the side effects of treatment, and cultural factors. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: HDR-BT, IMRT, perception, radiation, regret, satisfaction, SBRT, value | 1 Comment »
Earlier this year, in late May and early June, Prostate Cancer International (PCaI) conducted what we have described as a very primitive pilot survey on prostate cancer patients’ perceptions of “value” in the management of this disease. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: Diagnosis, Management, patient, results, survey, Treatment, value | 5 Comments »
When your sitemaster speaks to the assembled audience at the annual meeting of ASTRO this coming Sunday, one point he intends to make relates to the importance and value of clear, straightforward, high-quality communication between physicians and patients. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: communication, value | 3 Comments »
The question of whether digital rectal examinations (DREs) retain value in testing men for risk for prostate cancer (individual “screening”) has been controversial for many years now. Some men flatly refuse to have DREs for socio-cultural reasons. Others will put up with them, but they don’t like the idea. This is utterly unsurprising. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: digital, DRE, exam, rectal, test, value | 11 Comments »
Many years ago, among his other famous quotations on the subject of prostate cancer, Willet Whitmore, considered by many to be the “father” of urologic oncology, stated the following: … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: Management, outcome, Treatment, value | 2 Comments »
We have already received just under 600 responses to this survey in the first 2 weeks, but the survey will be accessible for a few more days before we take it down and start to analyze the data. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: survey, value | 13 Comments »
Many readers who weren’t able to join us on yesterday’s CureTalk panel discussion may want to listen to what was a wide-ranging discussion about things that are really valuable to prostate cancers patients at diagnosis and along their prostate cancer journey. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: care, information, quality, support, value | Leave a comment »
Healthcare and medicine have started to become engaged in what is liable to be a long and complex discussion about the “value” of different aspects of healthcare delivery. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: care, perception, value | Leave a comment »
The results of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), which have been published today in The Lancet, offer us some interesting insights into whether we will ever, actually, be able to prove that screening men for risk of prostate cancer reduces the risk of prostate cancer-specific death. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: mortality, risk, screening, value | 1 Comment »
Prostate Cancer International and The “New” Prostate Cancer InfoLink have never been supportive of the use of annual, mass, population-wide PSA screening of men over the ages of about 40 or 50 years as a way to identify risk for prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: PSA, screening, test, value | 7 Comments »
PET/CT scans using the radioactive fluorinated inhibitor of prostate-specific membrane antigen (PSMA) known as 18F-DCFBC (or just DCFBC) are better at detecting metastases … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management | Tagged: 18F-DCFBC, Diagnosis, PET/CT, scan, utility, value | 11 Comments »
According to what appears to have been a pretty forthright presentation at the ongoing annual meeting of the American Society for Radiation Oncology (ASTRO), many commonly used men’s health and prostate supplements weren’t helping prostate cancer patients. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: efficacy, safety, supplement, value | 8 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 